Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of hematotherapy

Showing results (51-60 of 369) with videos related to

Pageof 37
Sort By:
Journal of Hematotherapy|January 1, 1993
Genetic therapy of human neoplastic diseaseA B Deisseroth, E G Hanania, S Fu, et al.
Journal of Hematotherapy|January 1, 1994
Immunomagnetic colloids for the enrichment of tumor cells from peripheral blood and bone marrow: a model systemJ T Kemshead, J Hancock, P Liberti
Journal of Hematotherapy|January 1, 1994
Expansion and activation of human natural killer cells for autologous therapyJ S Miller, C Verfaillie, P McGlave
Journal of Hematotherapy|January 1, 1994
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2aA Nagler, A Ackerstein, V Barak, et al.
Journal of Hematotherapy|June 1, 1997
Enumeration of CD34-positive stem cells: evaluation and comparison of three methodsL C Sims, M E Brecher, K Gertis, et al.
Journal of Hematotherapy|October 1, 1995
A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeuticsI A Heijnen, J G Van de Winkel
Journal of Hematotherapy|October 1, 1995
In vivo studies using bispecific antibodies (anti-CD3 x anti-idiotype) and CD28-induced costimulation in the BCL1 lymphomaC Demanet, J Brissinck, J De Jonge, et al.
Journal of Hematotherapy|October 1, 1995
Alternative triggering molecules and single chain bispecific antibodiesD M Segal, G Sconocchia, J A Titus, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directionsS Canevari, D Mezzanzanica, A Mazzoni, et al.
Journal of Hematotherapy|October 1, 1995
Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodiesS Sforzini, A Bolognesi, R Meazza, et al.
Pageof 37

Showing results (51-60 of 369) with videos related to

Sort By:
Pageof 37
Journal of Hematotherapy|January 1, 1993
Genetic therapy of human neoplastic diseaseA B Deisseroth, E G Hanania, S Fu, et al.
Journal of Hematotherapy|January 1, 1994
Immunomagnetic colloids for the enrichment of tumor cells from peripheral blood and bone marrow: a model systemJ T Kemshead, J Hancock, P Liberti
Journal of Hematotherapy|January 1, 1994
Expansion and activation of human natural killer cells for autologous therapyJ S Miller, C Verfaillie, P McGlave
Journal of Hematotherapy|January 1, 1994
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2aA Nagler, A Ackerstein, V Barak, et al.
Journal of Hematotherapy|June 1, 1997
Enumeration of CD34-positive stem cells: evaluation and comparison of three methodsL C Sims, M E Brecher, K Gertis, et al.
Journal of Hematotherapy|October 1, 1995
A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeuticsI A Heijnen, J G Van de Winkel
Journal of Hematotherapy|October 1, 1995
In vivo studies using bispecific antibodies (anti-CD3 x anti-idiotype) and CD28-induced costimulation in the BCL1 lymphomaC Demanet, J Brissinck, J De Jonge, et al.
Journal of Hematotherapy|October 1, 1995
Alternative triggering molecules and single chain bispecific antibodiesD M Segal, G Sconocchia, J A Titus, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directionsS Canevari, D Mezzanzanica, A Mazzoni, et al.
Journal of Hematotherapy|October 1, 1995
Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodiesS Sforzini, A Bolognesi, R Meazza, et al.
Pageof 37